[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349904-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-349904-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","association-between-myosteatosis-and-survival-of-patients-with-esophageal-and-gastro-esophageal-junction-cancer-a-meta-analysis","Association between myosteatosis and survival of patients with esophageal and gastro-esophageal junction cancer - a meta-analysis","","Myosteatosis, a marker of fatty infiltration in skeletal muscle, is evaluated as a prognostic factor for patients with esophageal cancer (EC) or gastro-esophageal junction cancer (GEC). This meta-analysis systematically searched PubMed, Embase, and Web of Science through May 14, 2025. Eleven cohort studies with 1,810 patients were included. Baseline myosteatosis predicted worse overall survival, while progression-free survival showed no significant association. Muscle quality assessment may improve prognostic stratification for this population.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/association-between-myosteatosis-and-survival-of-patients-with-esophageal-and-gastro-esophageal-junction-cancer-a-meta-analysis/349904/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/association-between-myosteatosis-and-survival-of-patients-with-esophageal-and-gastro-esophageal-junction-cancer-a-meta-analysis/349904.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the meta-analysis address?","Question",{"text":63,"@type":64},"Whether baseline myosteatosis is associated with survival outcomes in patients with esophageal cancer or gastro-esophageal junction cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were eligible studies selected and analyzed?",{"text":68,"@type":64},"Studies were identified from PubMed, Embase, and Web of Science through May 14, 2025, including cohorts reporting overall survival and/or progression-free survival by baseline myosteatosis status; pooled hazard ratios were estimated using random-effects models.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main findings regarding survival?",{"text":72,"@type":64},"Myosteatosis was significantly associated with poorer overall survival, while progression-free survival did not show a significant association.",{"name":74,"@type":61,"acceptedAnswer":75},"Does the method of assessing myosteatosis matter?",{"text":76,"@type":64},"Yes. A stronger effect was observed when myosteatosis was assessed using intramuscular adipose tissue content rather than muscle attenuation.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},349904,1790164622,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Submitted 2 September 2025  \nAccepted 30 December 2025  \nPublished 17 February 2026  \nCorresponding author  \nWu Wang, [wangwufjmu@163.com](wangwufjmu@163.com)[ ](wangwufjmu@163.com)Academic editor  \nFaiza Farhan  \nAdditional Information and Declarations can be found on page 18  \nDOI 10.7717/peerj.20825  \n Copyright 2026 Wang et al.  \nDistributed under  \nCreative Commons CC-BY-NC 4.0  \nOPEN ACCESS  \nAssociation between myosteatosis and survival of patients with esophageal and gastro-esophageal junction cancer: a meta-analysis  \nWu Wang1 ,2 , Jinbiao Xie2 , Tianbao Yang2 , Shijie Huang2 and Boyang Chen2  \n1 School of Clinical Medicine, Fujian Medical University, Fuzhou, China  \n2 Department of Cardiothoracic Surgery, The Affiliated Hospital of Putian University, Putian, China  \nABSTRACT  \nBackground. Myosteatosis, a marker of fatty infiltration in skeletal muscle, has emerged as a potential prognostic factor in various cancers. However, its association with survival in patients with esophageal cancer (EC) or gastro-esophageal junction cancer (GEC) remains uncertain. This meta-analysis aimed to evaluate the predictive value of myosteatosis for survival of this patient population.  \nMethods. A systematic search of PubMed, Embase, and Web of Science was conducted through May 14, 2025 . Studies reporting overall survival (OS) and/or progressionfree survival (PFS) in patients with EC or GEC, with outcomes stratified by baseline myosteatosis status, were eligible for inclusion. To account for inter-study variability, pooled hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) were estimated using random-effects models.  \nResults. Eleven cohort studies comprising 1,810 patients withECor GEC were included. Myosteatosis was significantly associated with poorer OS (HR D 1.46, 95% CI [1.13􀀕 1.88], p D 0:004; I2 D 76%) . Subgroup analyses indicated consistent associations across study design, cancer type, age, sex, treatment modality, and analytic models (p for subgroup differences > 0.05) . A stronger effect was observed when myosteatosis was assessed using intramuscular adipose tissue content rather than muscle attenuation (HRD 2.29 vs. 1.30; p for subgroup difference D 0.02) . Myosteatosis was not significantly associated with PFS (HR D 1.29, 95% CI [0 .77􀀕2 . 18], p D 0:34; I2 D 82%) . Conclusion. Baseline myosteatosis is associated with poorer OS in patients with EC or GEC. Muscle quality assessment may improve prognostic stratification in this population.  \nSubjects Evidence Based Medicine, Oncology, Pathology, Radiology and Medical Imaging, Metabolic Sciences  \nKeywords Esophageal cancer, Gastroesophageal junction cancer, Myosteatosis, Progression, Survival  \nINTRODUCTION  \nEsophageal cancer (EC) continues to pose a major public health challenge globally, currently ranking as the eighth most commonly diagnosed cancer and the sixth leading cause of cancer-related deaths worldwide (Liu et al., 2023a; Siegel et al., 2025) . The disease  \nHow to cite this article Wang W, Xie J, Yang T, Huang S, Chen B. 2026. Association between myosteatosis and survival of patients with esophageal and gastro-esophageal junction cancer: a meta-analysis. PeerJ 14:e20825 [http://doi.org/10.7717/peerj.20825](http://doi.org/10.7717/peerj.20825)  \nis typically diagnosed at an advanced stage, contributing to its dismal prognosis, with 5-year overall survival rates ranging from 15% to 25% despite advances in multimodal therapies including surgery, chemotherapy, and radiotherapy (Cummings et al., 2021) . Given the close anatomical location, overlapping biological behavior, and similar treatment approaches, gastro-esophageal junction cancer (GEC) is often grouped with EC in clinical studies (Cellini et al., 2014) . Accurate prognostic stratification is crucial for guiding therapeutic decision-making and optimizing outcomes. While traditional tumor-related factors such as stage, histology, and lymph node involvement are well-established predictors o","cbCaia7EazRhJgME","https://ap.wps.com/l/cbCaia7EazRhJgME","pdf",16533870,23,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Clinical challenge and prognostic stratification\n## Myosteatosis assessment and rationale","[{\"question\":\"What question does the meta-analysis address?\",\"answer\":\"Whether baseline myosteatosis is associated with survival outcomes in patients with esophageal cancer or gastro-esophageal junction cancer.\"},{\"question\":\"How were eligible studies selected and analyzed?\",\"answer\":\"Studies were identified from PubMed, Embase, and Web of Science through May 14, 2025, including cohorts reporting overall survival and/or progression-free survival by baseline myosteatosis status; pooled hazard ratios were estimated using random-effects models.\"},{\"question\":\"What were the main findings regarding survival?\",\"answer\":\"Myosteatosis was significantly associated with poorer overall survival, while progression-free survival did not show a significant association.\"},{\"question\":\"Does the method of assessing myosteatosis matter?\",\"answer\":\"Yes. A stronger effect was observed when myosteatosis was assessed using intramuscular adipose tissue content rather than muscle attenuation.\"}]","Association between myosteatosis and survival of patients with esophageal and gastro-esophageal junction cancer - a meta-analysis | PDF",1790086168,58,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b6bcee5d18025bed0215b74f48f33b1.webp",983,1272,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bd2098a74a349dd8df8dd063655c8a1.webp",982,1270,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/025990a84a410e4245304e055904d612.webp",981,1269,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fcd46586a019ae87ebc788f18fa8936.webp",980,1268]